nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—acquired immunodeficiency syndrome—sarcoma	0.907	1	CtDrD
Didanosine—PNP—hematopoietic system—sarcoma	0.00213	0.111	CbGeAlD
Didanosine—PNP—uterus—sarcoma	0.00161	0.0839	CbGeAlD
Didanosine—PNP—lymphoid tissue—sarcoma	0.0015	0.0782	CbGeAlD
Didanosine—PNP—bone marrow—sarcoma	0.00137	0.0712	CbGeAlD
Didanosine—SLC29A1—mammary gland—sarcoma	0.0013	0.0679	CbGeAlD
Didanosine—PNP—Daunorubicin—Epirubicin—sarcoma	0.00126	0.519	CbGdCrCtD
Didanosine—SLC29A2—cardiac atrium—sarcoma	0.00121	0.0633	CbGeAlD
Didanosine—PNP—Daunorubicin—Doxorubicin—sarcoma	0.00117	0.48	CbGdCrCtD
Didanosine—PNP—liver—sarcoma	0.0011	0.0575	CbGeAlD
Didanosine—SLC29A2—tendon—sarcoma	0.00106	0.0552	CbGeAlD
Didanosine—SLC29A1—myometrium—sarcoma	0.000924	0.0482	CbGeAlD
Didanosine—SLC29A2—liver—sarcoma	0.000829	0.0432	CbGeAlD
Didanosine—SLC29A1—hematopoietic system—sarcoma	0.000793	0.0414	CbGeAlD
Didanosine—SLC29A1—connective tissue—sarcoma	0.000764	0.0398	CbGeAlD
Didanosine—SLC29A2—lymph node—sarcoma	0.000635	0.0331	CbGeAlD
Didanosine—SLC29A1—cardiac atrium—sarcoma	0.000602	0.0314	CbGeAlD
Didanosine—SLC29A1—uterus—sarcoma	0.000599	0.0312	CbGeAlD
Didanosine—SLC29A1—lymphoid tissue—sarcoma	0.000558	0.0291	CbGeAlD
Didanosine—SLC29A1—tendon—sarcoma	0.000525	0.0274	CbGeAlD
Didanosine—SLC29A1—bone marrow—sarcoma	0.000508	0.0265	CbGeAlD
Didanosine—SLC29A1—testis—sarcoma	0.000435	0.0227	CbGeAlD
Didanosine—SLC29A1—liver—sarcoma	0.000411	0.0214	CbGeAlD
Didanosine—Anaphylactoid reaction—Etoposide—sarcoma	0.000356	0.00496	CcSEcCtD
Didanosine—Hepatobiliary disease—Thiotepa—sarcoma	0.000349	0.00487	CcSEcCtD
Didanosine—Hepatomegaly—Doxorubicin—sarcoma	0.000348	0.00484	CcSEcCtD
Didanosine—Agranulocytosis—Thiotepa—sarcoma	0.000345	0.0048	CcSEcCtD
Didanosine—Agranulocytosis—Dactinomycin—sarcoma	0.000342	0.00477	CcSEcCtD
Didanosine—Neuritis—Doxorubicin—sarcoma	0.00033	0.00459	CcSEcCtD
Didanosine—Hepatitis—Dactinomycin—sarcoma	0.000329	0.00459	CcSEcCtD
Didanosine—Hyperglycaemia—Mitoxantrone—sarcoma	0.000323	0.0045	CcSEcCtD
Didanosine—Neuropathy peripheral—Vincristine—sarcoma	0.000321	0.00447	CcSEcCtD
Didanosine—Blood disorder—Epirubicin—sarcoma	0.000318	0.00444	CcSEcCtD
Didanosine—Liver injury—Epirubicin—sarcoma	0.000316	0.0044	CcSEcCtD
Didanosine—SLC29A1—lymph node—sarcoma	0.000315	0.0164	CbGeAlD
Didanosine—Agranulocytosis—Mitoxantrone—sarcoma	0.000298	0.00415	CcSEcCtD
Didanosine—Chills—Thiotepa—sarcoma	0.000298	0.00415	CcSEcCtD
Didanosine—Chills—Dactinomycin—sarcoma	0.000295	0.00411	CcSEcCtD
Didanosine—Blood disorder—Doxorubicin—sarcoma	0.000295	0.0041	CcSEcCtD
Didanosine—Alopecia—Thiotepa—sarcoma	0.000293	0.00408	CcSEcCtD
Didanosine—Hypoaesthesia—Vincristine—sarcoma	0.000293	0.00408	CcSEcCtD
Didanosine—Liver injury—Doxorubicin—sarcoma	0.000292	0.00407	CcSEcCtD
Didanosine—Alopecia—Dactinomycin—sarcoma	0.000291	0.00405	CcSEcCtD
Didanosine—Hyperuricaemia—Epirubicin—sarcoma	0.000287	0.00399	CcSEcCtD
Didanosine—Hepatitis—Mitoxantrone—sarcoma	0.000286	0.00399	CcSEcCtD
Didanosine—Inflammation—Epirubicin—sarcoma	0.000274	0.00382	CcSEcCtD
Didanosine—Blood uric acid increased—Epirubicin—sarcoma	0.000271	0.00377	CcSEcCtD
Didanosine—Anaemia—Thiotepa—sarcoma	0.000267	0.00372	CcSEcCtD
Didanosine—Hepatocellular injury—Epirubicin—sarcoma	0.000266	0.0037	CcSEcCtD
Didanosine—Hyperuricaemia—Doxorubicin—sarcoma	0.000265	0.0037	CcSEcCtD
Didanosine—Anaemia—Dactinomycin—sarcoma	0.000265	0.00369	CcSEcCtD
Didanosine—Neuropathy peripheral—Etoposide—sarcoma	0.00026	0.00362	CcSEcCtD
Didanosine—Alopecia—Vincristine—sarcoma	0.00026	0.00362	CcSEcCtD
Didanosine—Leukopenia—Thiotepa—sarcoma	0.000258	0.0036	CcSEcCtD
Didanosine—Malaise—Dactinomycin—sarcoma	0.000258	0.0036	CcSEcCtD
Didanosine—Chills—Mitoxantrone—sarcoma	0.000257	0.00358	CcSEcCtD
Didanosine—Leukopenia—Dactinomycin—sarcoma	0.000257	0.00357	CcSEcCtD
Didanosine—Inflammation—Doxorubicin—sarcoma	0.000254	0.00353	CcSEcCtD
Didanosine—Alopecia—Mitoxantrone—sarcoma	0.000253	0.00353	CcSEcCtD
Didanosine—Hepatobiliary disease—Etoposide—sarcoma	0.000251	0.0035	CcSEcCtD
Didanosine—Blood uric acid increased—Doxorubicin—sarcoma	0.000251	0.00349	CcSEcCtD
Didanosine—Neuropathy—Epirubicin—sarcoma	0.00025	0.00348	CcSEcCtD
Didanosine—Agranulocytosis—Etoposide—sarcoma	0.000248	0.00345	CcSEcCtD
Didanosine—Hepatocellular injury—Doxorubicin—sarcoma	0.000246	0.00343	CcSEcCtD
Didanosine—Arthralgia—Thiotepa—sarcoma	0.000246	0.00342	CcSEcCtD
Didanosine—Myalgia—Thiotepa—sarcoma	0.000246	0.00342	CcSEcCtD
Didanosine—Dry eye—Epirubicin—sarcoma	0.000246	0.00342	CcSEcCtD
Didanosine—Myalgia—Dactinomycin—sarcoma	0.000244	0.0034	CcSEcCtD
Didanosine—Discomfort—Dactinomycin—sarcoma	0.000241	0.00336	CcSEcCtD
Didanosine—Hypoaesthesia—Etoposide—sarcoma	0.000237	0.0033	CcSEcCtD
Didanosine—Anaemia—Vincristine—sarcoma	0.000237	0.0033	CcSEcCtD
Didanosine—Infection—Thiotepa—sarcoma	0.000234	0.00326	CcSEcCtD
Didanosine—Infection—Dactinomycin—sarcoma	0.000232	0.00324	CcSEcCtD
Didanosine—Neuropathy—Doxorubicin—sarcoma	0.000231	0.00322	CcSEcCtD
Didanosine—Thrombocytopenia—Thiotepa—sarcoma	0.000231	0.00321	CcSEcCtD
Didanosine—Anaemia—Mitoxantrone—sarcoma	0.00023	0.00321	CcSEcCtD
Didanosine—Leukopenia—Vincristine—sarcoma	0.000229	0.00319	CcSEcCtD
Didanosine—Thrombocytopenia—Dactinomycin—sarcoma	0.000229	0.00319	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—sarcoma	0.000227	0.00317	CcSEcCtD
Didanosine—Malaise—Mitoxantrone—sarcoma	0.000225	0.00313	CcSEcCtD
Didanosine—Anorexia—Thiotepa—sarcoma	0.000225	0.00313	CcSEcCtD
Didanosine—Leukopenia—Mitoxantrone—sarcoma	0.000223	0.00311	CcSEcCtD
Didanosine—Anorexia—Dactinomycin—sarcoma	0.000223	0.00311	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.000222	0.00309	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—sarcoma	0.000222	0.00309	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—sarcoma	0.000221	0.00308	CcSEcCtD
Didanosine—Myalgia—Vincristine—sarcoma	0.000218	0.00304	CcSEcCtD
Didanosine—Hepatic failure—Epirubicin—sarcoma	0.000215	0.00299	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000215	0.00299	CcSEcCtD
Didanosine—Chills—Etoposide—sarcoma	0.000214	0.00298	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000213	0.00297	CcSEcCtD
Didanosine—Arthralgia—Mitoxantrone—sarcoma	0.000212	0.00296	CcSEcCtD
Didanosine—Myalgia—Mitoxantrone—sarcoma	0.000212	0.00296	CcSEcCtD
Didanosine—Paraesthesia—Thiotepa—sarcoma	0.000212	0.00295	CcSEcCtD
Didanosine—Alopecia—Etoposide—sarcoma	0.000211	0.00293	CcSEcCtD
Didanosine—Discomfort—Mitoxantrone—sarcoma	0.00021	0.00292	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—sarcoma	0.000209	0.00291	CcSEcCtD
Didanosine—Anaphylactic shock—Vincristine—sarcoma	0.000209	0.00291	CcSEcCtD
Didanosine—Infection—Vincristine—sarcoma	0.000208	0.00289	CcSEcCtD
Didanosine—Dyspepsia—Thiotepa—sarcoma	0.000207	0.00289	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—sarcoma	0.000205	0.00286	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000205	0.00286	CcSEcCtD
Didanosine—Decreased appetite—Thiotepa—sarcoma	0.000205	0.00285	CcSEcCtD
Didanosine—Thrombocytopenia—Vincristine—sarcoma	0.000205	0.00285	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—sarcoma	0.000204	0.00285	CcSEcCtD
Didanosine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000204	0.00283	CcSEcCtD
Didanosine—Decreased appetite—Dactinomycin—sarcoma	0.000203	0.00283	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—sarcoma	0.000203	0.00283	CcSEcCtD
Didanosine—Infection—Mitoxantrone—sarcoma	0.000202	0.00282	CcSEcCtD
Didanosine—Pain—Thiotepa—sarcoma	0.000202	0.00281	CcSEcCtD
Didanosine—Pain—Dactinomycin—sarcoma	0.0002	0.00279	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—sarcoma	0.000199	0.00278	CcSEcCtD
Didanosine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000199	0.00278	CcSEcCtD
Didanosine—Anorexia—Vincristine—sarcoma	0.000199	0.00277	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—sarcoma	0.000199	0.00277	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—sarcoma	0.000198	0.00276	CcSEcCtD
Didanosine—Anorexia—Mitoxantrone—sarcoma	0.000194	0.0027	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—sarcoma	0.000194	0.0027	CcSEcCtD
Didanosine—Gastrointestinal pain—Thiotepa—sarcoma	0.000193	0.00268	CcSEcCtD
Didanosine—Anaemia—Etoposide—sarcoma	0.000192	0.00267	CcSEcCtD
Didanosine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000191	0.00266	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00019	0.00265	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—sarcoma	0.000188	0.00261	CcSEcCtD
Didanosine—Paraesthesia—Vincristine—sarcoma	0.000188	0.00261	CcSEcCtD
Didanosine—Malaise—Etoposide—sarcoma	0.000187	0.00261	CcSEcCtD
Didanosine—Body temperature increased—Thiotepa—sarcoma	0.000186	0.00259	CcSEcCtD
Didanosine—Abdominal pain—Thiotepa—sarcoma	0.000186	0.00259	CcSEcCtD
Didanosine—Leukopenia—Etoposide—sarcoma	0.000186	0.00259	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000185	0.00258	CcSEcCtD
Didanosine—Abdominal pain—Dactinomycin—sarcoma	0.000185	0.00258	CcSEcCtD
Didanosine—Body temperature increased—Dactinomycin—sarcoma	0.000185	0.00258	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000185	0.00257	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—sarcoma	0.000183	0.00255	CcSEcCtD
Didanosine—Paraesthesia—Mitoxantrone—sarcoma	0.000183	0.00255	CcSEcCtD
Didanosine—Decreased appetite—Vincristine—sarcoma	0.000182	0.00253	CcSEcCtD
Didanosine—Dyspepsia—Mitoxantrone—sarcoma	0.000179	0.0025	CcSEcCtD
Didanosine—Pain—Vincristine—sarcoma	0.000179	0.00249	CcSEcCtD
Didanosine—Decreased appetite—Mitoxantrone—sarcoma	0.000177	0.00246	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—sarcoma	0.000176	0.00246	CcSEcCtD
Didanosine—Discomfort—Etoposide—sarcoma	0.000174	0.00243	CcSEcCtD
Didanosine—Pain—Mitoxantrone—sarcoma	0.000174	0.00242	CcSEcCtD
Didanosine—Hypersensitivity—Thiotepa—sarcoma	0.000174	0.00242	CcSEcCtD
Didanosine—Hypersensitivity—Dactinomycin—sarcoma	0.000172	0.0024	CcSEcCtD
Didanosine—Gastrointestinal pain—Vincristine—sarcoma	0.000171	0.00238	CcSEcCtD
Didanosine—Anaphylactic shock—Etoposide—sarcoma	0.000169	0.00236	CcSEcCtD
Didanosine—Asthenia—Thiotepa—sarcoma	0.000169	0.00236	CcSEcCtD
Didanosine—Infection—Etoposide—sarcoma	0.000168	0.00234	CcSEcCtD
Didanosine—Asthenia—Dactinomycin—sarcoma	0.000168	0.00234	CcSEcCtD
Didanosine—Pruritus—Thiotepa—sarcoma	0.000167	0.00232	CcSEcCtD
Didanosine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000166	0.00232	CcSEcCtD
Didanosine—Thrombocytopenia—Etoposide—sarcoma	0.000166	0.00231	CcSEcCtD
Didanosine—Abdominal pain—Vincristine—sarcoma	0.000165	0.0023	CcSEcCtD
Didanosine—Body temperature increased—Vincristine—sarcoma	0.000165	0.0023	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—sarcoma	0.000164	0.00228	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—sarcoma	0.000163	0.00227	CcSEcCtD
Didanosine—Anorexia—Etoposide—sarcoma	0.000161	0.00225	CcSEcCtD
Didanosine—Diarrhoea—Thiotepa—sarcoma	0.000161	0.00225	CcSEcCtD
Didanosine—Abdominal pain—Mitoxantrone—sarcoma	0.000161	0.00224	CcSEcCtD
Didanosine—Body temperature increased—Mitoxantrone—sarcoma	0.000161	0.00224	CcSEcCtD
Didanosine—Diarrhoea—Dactinomycin—sarcoma	0.00016	0.00223	CcSEcCtD
Didanosine—Hypersensitivity—Vincristine—sarcoma	0.000154	0.00214	CcSEcCtD
Didanosine—Paraesthesia—Etoposide—sarcoma	0.000152	0.00212	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—sarcoma	0.000151	0.00211	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—sarcoma	0.000151	0.0021	CcSEcCtD
Didanosine—Hypersensitivity—Mitoxantrone—sarcoma	0.00015	0.00209	CcSEcCtD
Didanosine—Asthenia—Vincristine—sarcoma	0.00015	0.00209	CcSEcCtD
Didanosine—Vomiting—Thiotepa—sarcoma	0.00015	0.00209	CcSEcCtD
Didanosine—Vomiting—Dactinomycin—sarcoma	0.000149	0.00207	CcSEcCtD
Didanosine—Rash—Thiotepa—sarcoma	0.000149	0.00207	CcSEcCtD
Didanosine—Dermatitis—Thiotepa—sarcoma	0.000148	0.00207	CcSEcCtD
Didanosine—Headache—Thiotepa—sarcoma	0.000148	0.00206	CcSEcCtD
Didanosine—Rash—Dactinomycin—sarcoma	0.000147	0.00205	CcSEcCtD
Didanosine—Decreased appetite—Etoposide—sarcoma	0.000147	0.00205	CcSEcCtD
Didanosine—Asthenia—Mitoxantrone—sarcoma	0.000146	0.00203	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—sarcoma	0.000146	0.00203	CcSEcCtD
Didanosine—Pain—Etoposide—sarcoma	0.000145	0.00202	CcSEcCtD
Didanosine—Diarrhoea—Vincristine—sarcoma	0.000143	0.00199	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—sarcoma	0.000141	0.00196	CcSEcCtD
Didanosine—Nausea—Thiotepa—sarcoma	0.00014	0.00195	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—sarcoma	0.000139	0.00194	CcSEcCtD
Didanosine—Diarrhoea—Mitoxantrone—sarcoma	0.000139	0.00194	CcSEcCtD
Didanosine—Nausea—Dactinomycin—sarcoma	0.000139	0.00194	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—sarcoma	0.000139	0.00193	CcSEcCtD
Didanosine—Gastrointestinal pain—Etoposide—sarcoma	0.000138	0.00193	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000135	0.00188	CcSEcCtD
Didanosine—Abdominal pain—Etoposide—sarcoma	0.000134	0.00186	CcSEcCtD
Didanosine—Body temperature increased—Etoposide—sarcoma	0.000134	0.00186	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—sarcoma	0.000134	0.00186	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—sarcoma	0.000133	0.00185	CcSEcCtD
Didanosine—Vomiting—Vincristine—sarcoma	0.000133	0.00185	CcSEcCtD
Didanosine—Rash—Vincristine—sarcoma	0.000132	0.00184	CcSEcCtD
Didanosine—Dermatitis—Vincristine—sarcoma	0.000132	0.00183	CcSEcCtD
Didanosine—Headache—Vincristine—sarcoma	0.000131	0.00182	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—sarcoma	0.00013	0.00181	CcSEcCtD
Didanosine—Vomiting—Mitoxantrone—sarcoma	0.000129	0.0018	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—sarcoma	0.000128	0.00179	CcSEcCtD
Didanosine—Rash—Mitoxantrone—sarcoma	0.000128	0.00179	CcSEcCtD
Didanosine—Dermatitis—Mitoxantrone—sarcoma	0.000128	0.00179	CcSEcCtD
Didanosine—Headache—Mitoxantrone—sarcoma	0.000128	0.00178	CcSEcCtD
Didanosine—Hypersensitivity—Etoposide—sarcoma	0.000125	0.00174	CcSEcCtD
Didanosine—Nausea—Vincristine—sarcoma	0.000124	0.00173	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—sarcoma	0.000124	0.00172	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—sarcoma	0.000123	0.00171	CcSEcCtD
Didanosine—Asthenia—Etoposide—sarcoma	0.000121	0.00169	CcSEcCtD
Didanosine—Nausea—Mitoxantrone—sarcoma	0.000121	0.00168	CcSEcCtD
Didanosine—Chills—Epirubicin—sarcoma	0.00012	0.00167	CcSEcCtD
Didanosine—Pruritus—Etoposide—sarcoma	0.00012	0.00167	CcSEcCtD
Didanosine—Alopecia—Epirubicin—sarcoma	0.000118	0.00164	CcSEcCtD
Didanosine—Diarrhoea—Etoposide—sarcoma	0.000116	0.00161	CcSEcCtD
Didanosine—Flatulence—Epirubicin—sarcoma	0.000115	0.0016	CcSEcCtD
Didanosine—Chills—Doxorubicin—sarcoma	0.000111	0.00154	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—sarcoma	0.000109	0.00152	CcSEcCtD
Didanosine—Vomiting—Etoposide—sarcoma	0.000108	0.0015	CcSEcCtD
Didanosine—Anaemia—Epirubicin—sarcoma	0.000107	0.0015	CcSEcCtD
Didanosine—Rash—Etoposide—sarcoma	0.000107	0.00149	CcSEcCtD
Didanosine—Dermatitis—Etoposide—sarcoma	0.000107	0.00149	CcSEcCtD
Didanosine—Headache—Etoposide—sarcoma	0.000106	0.00148	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—sarcoma	0.000106	0.00148	CcSEcCtD
Didanosine—Malaise—Epirubicin—sarcoma	0.000105	0.00146	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—sarcoma	0.000104	0.00145	CcSEcCtD
Didanosine—Nausea—Etoposide—sarcoma	0.000101	0.0014	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—sarcoma	9.94e-05	0.00138	CcSEcCtD
Didanosine—Myalgia—Epirubicin—sarcoma	9.9e-05	0.00138	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—sarcoma	9.9e-05	0.00138	CcSEcCtD
Didanosine—Discomfort—Epirubicin—sarcoma	9.78e-05	0.00136	CcSEcCtD
Didanosine—Malaise—Doxorubicin—sarcoma	9.7e-05	0.00135	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—sarcoma	9.68e-05	0.00135	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—sarcoma	9.63e-05	0.00134	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—sarcoma	9.49e-05	0.00132	CcSEcCtD
Didanosine—Infection—Epirubicin—sarcoma	9.43e-05	0.00131	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—sarcoma	9.29e-05	0.00129	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—sarcoma	9.16e-05	0.00128	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—sarcoma	9.16e-05	0.00128	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—sarcoma	9.05e-05	0.00126	CcSEcCtD
Didanosine—Anorexia—Epirubicin—sarcoma	9.05e-05	0.00126	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—sarcoma	8.96e-05	0.00125	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—sarcoma	8.78e-05	0.00122	CcSEcCtD
Didanosine—Infection—Doxorubicin—sarcoma	8.72e-05	0.00121	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—sarcoma	8.65e-05	0.0012	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—sarcoma	8.6e-05	0.0012	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—sarcoma	8.52e-05	0.00119	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—sarcoma	8.37e-05	0.00117	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—sarcoma	8.35e-05	0.00116	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—sarcoma	8.25e-05	0.00115	CcSEcCtD
Didanosine—Pain—Epirubicin—sarcoma	8.12e-05	0.00113	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—sarcoma	8e-05	0.00111	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—sarcoma	7.88e-05	0.0011	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—sarcoma	7.76e-05	0.00108	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—sarcoma	7.73e-05	0.00108	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—sarcoma	7.63e-05	0.00106	CcSEcCtD
Didanosine—Pain—Doxorubicin—sarcoma	7.51e-05	0.00105	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—sarcoma	7.5e-05	0.00104	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—sarcoma	7.5e-05	0.00104	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—sarcoma	7.18e-05	0.001	CcSEcCtD
Didanosine—Hypersensitivity—Epirubicin—sarcoma	6.99e-05	0.000974	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—sarcoma	6.94e-05	0.000967	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—sarcoma	6.94e-05	0.000967	CcSEcCtD
Didanosine—Asthenia—Epirubicin—sarcoma	6.81e-05	0.000948	CcSEcCtD
Didanosine—Pruritus—Epirubicin—sarcoma	6.71e-05	0.000935	CcSEcCtD
Didanosine—Diarrhoea—Epirubicin—sarcoma	6.49e-05	0.000904	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—sarcoma	6.47e-05	0.000901	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—sarcoma	6.3e-05	0.000877	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—sarcoma	6.21e-05	0.000865	CcSEcCtD
Didanosine—Vomiting—Epirubicin—sarcoma	6.03e-05	0.00084	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—sarcoma	6.01e-05	0.000837	CcSEcCtD
Didanosine—Rash—Epirubicin—sarcoma	5.98e-05	0.000833	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—sarcoma	5.98e-05	0.000833	CcSEcCtD
Didanosine—Headache—Epirubicin—sarcoma	5.95e-05	0.000828	CcSEcCtD
Didanosine—Nausea—Epirubicin—sarcoma	5.64e-05	0.000785	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—sarcoma	5.58e-05	0.000778	CcSEcCtD
Didanosine—Rash—Doxorubicin—sarcoma	5.54e-05	0.000771	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—sarcoma	5.53e-05	0.00077	CcSEcCtD
Didanosine—Headache—Doxorubicin—sarcoma	5.5e-05	0.000766	CcSEcCtD
Didanosine—Nausea—Doxorubicin—sarcoma	5.22e-05	0.000726	CcSEcCtD
